Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Assets: 2023-2025

Historic Current Assets for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $77.7 million.

  • Camp4 Therapeutics' Current Assets rose 1311.85% to $77.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.7 million, marking a year-over-year increase of 1311.85%. This contributed to the annual value of $66.4 million for FY2024, which is 65.90% up from last year.
  • Per Camp4 Therapeutics' latest filing, its Current Assets stood at $77.7 million for Q3 2025, which was up 89.13% from $41.1 million recorded in Q2 2025.
  • Camp4 Therapeutics' Current Assets' 5-year high stood at $77.7 million during Q3 2025, with a 5-year trough of $5.5 million in Q3 2024.
  • Over the past 3 years, Camp4 Therapeutics' median Current Assets value was $46.4 million (recorded in 2025), while the average stood at $47.1 million.
  • Data for Camp4 Therapeutics' Current Assets shows a peak YoY soared of 1,311.85% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Current Assets stood at $40.0 million in 2023, then surged by 65.90% to $66.4 million in 2024, then spiked by 1,311.85% to $77.7 million in 2025.
  • Its Current Assets was $77.7 million in Q3 2025, compared to $41.1 million in Q2 2025 and $51.7 million in Q1 2025.